NanJing Pharmaceutical Company Limited (600713.SS) SHH

4.96

-0.01(-0.20%)

Updated at October 20 09:51AM

Currency In CNY

Valuation

Market Cap6.46B
Enterprise Value9.4B
P/E Ratio11.86
PEG Ratio-1.82
Price/Sales Ratio0.12
Price/Book Ratio0.95
Enterprise/Revenue0.23
Enterprise/EBITDA9.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.08

Income Statement

Revenue53.7B
Revenue/Share41.43
Gross Profit3.37B
EBITDA1.67B
Net Income570.63M
Diluted EPS0.44

Balance Sheet

Total Cash2.39B
Total Cash/Share1.82
Total Debt8.17B
Total Debt/Equity1.19
Current Ratio1.46
Book Value Per Share5.98

Price History

52-Week Change6.2
52-Week High5.64
52-Week Low4.55
Moving Average 50 Days5.06
Moving Average 200 Days5.05

Statistics

Average Volume13.91M
Shares Outstanding1.31B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.17
Trailing Annual Dividend Yield3.42
Payout Ratio0.85
Last Split Factor2:1
Last Split DateJuly 08, 2011